Kjersti Flatmark - Publications

Pooled analysis of 2 clinical trials of first-line chemoimmunotherapy for metastatic microsatellite stable colorectal cancer MEDITREME and METIMMOX studies.

Journal: Oncoimmunology

Published: June 20, 2026

Limited clinical utility of mutation-based circulating tumor DNA detection in pseudomyxoma peritonei.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: February 23, 2026

Carcinoembryonic Antigen Flare Under Oxaliplatin-Based Chemotherapy Predicts Benefit from Nivolumab in Metastatic Microsatellite-Stable Colorectal Cancer - A Post Hoc Analysis of METIMMOX Trial Data.

Journal: ImmunoTargets and therapy

Published: January 09, 2026

ASO Visual Abstract: Intraperitoneal Perfusion with Cisplatin or Mitomycin C Improves Survival in Mice Bearing Peritoneal Metastases from Ovarian Cancer.

Journal: Annals of surgical oncology

Published: October 04, 2025

High prevalence of KRAS and GNAS mutations in pseudomyxoma peritonei underscores opportunities for targeted therapeutic strategies.

Journal: Pleura and peritoneum

Published: September 19, 2025

Exploratory biomarkers for oxaliplatin-induced nivolumab responsiveness in metastatic microsatellite-stable colorectal cancer.

Journal: British journal of cancer

Published: August 13, 2025

Intraperitoneal Perfusion with Cisplatin or Mitomycin C Improves Survival in Mice Bearing Peritoneal Metastases from Ovarian Cancer.

Journal: Annals of surgical oncology

Published: March 17, 2025

Peritoneal Surface Oncology surgery: Reflections on key determinants of success for female surgeons in this challenging discipline.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: February 15, 2025

Early detection of deep pelvic surgical site infection by microdialysis after abdominoperineal resection for locally advanced rectal cancer.

Journal: Techniques in coloproctology

Published: January 24, 2025

Pan-carcinoma sialyl-Tn-targeting expands CAR therapy to solid tumors.

Journal: Cell reports. Medicine

Published: January 03, 2025

Low-intensity induction chemotherapy before chemoradiotherapy for rectal cancer: 10-year overall survival in the LARC-RRP trial.

Journal: The British journal of radiology

Published: October 04, 2024

Enrichment of Cancer-Associated Fibroblasts, Macrophages, and Up-Regulated TNF-α Signaling in the Tumor Microenvironment of CMS4 Colorectal Peritoneal Metastasis.

Journal: Cancer medicine

Published: August 29, 2024